Evidence map›Paper›PMID 15601931›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.

Paulo Dinis, Ana Charrua, Antonio Avelino, Mohammed Yaqoob, Stuart Bevan, Istvan Nagy, Francisco Cruz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 204 citations in OpenAlex.

  1. Trial
  2. Article
  3. Mechanosensing Piezo channels in gastrointestinal disorders.The Journal of clinical investigation · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Potential of Endocannabinoids to Control Bladder Pain.Frontiers in systems neuroscience · 2018
    Review
  13. Article
  14. Article
  15. Review
  16. Capsaicin, Nociception and Pain.Molecules (Basel, Switzerland) · 2016
    Review
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Paulo DinisInstitute of Histology and Embryology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Ana Charrua
Antonio Avelino
Mohammed Yaqoob
Stuart Bevan
Istvan Nagy
Francisco Cruz
Universidade do Porto · PTHospital de São João · PTHungarian Academy of Sciences · HUNovartis (Switzerland) · CHNovartis (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of anandamide in the development of inflammatory hyperalgesia and visceral hyperreflexia was studied in the rat urinary bladder. Animals were given intraperitoneal cyclophosphamide injection, which evokes painful hemorrhagic cystitis accompanied by increased bladder reflex activity. The vanilloid receptor 1 [transient receptor potential vanilloid 1 (TRPV1)] antagonist capsazepine, applied onto the serosal surface of bladders, significantly reduced the hyperreflexia. Mass spectrometric analysis revealed that cyclophosphamide injection significantly and persistently increased the anandamide content of bladder tissues. The increase in the anandamide content paralleled the development of reflex hyperactivity. Anandamide (1-100 microm), applied onto the serosal surface of naive bladders, increased the reflex activity in a concentration-dependent manner. Repeated anandamide applications did not produce desensitization of the response. The anandamide-evoked effect was blocked by capsazepine or by instillation of resiniferatoxin, the ultrapotent TRPV1 agonist, into the bladders 24 hr before the anandamide challenge. The cannabinoid 1 receptor antagonist SR141716A [N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide] significantly increased the potency of anandamide in enhancing bladder reflex activity in naive but not in cyclophosphamide-injected animals. Application of the fatty acid amide hydrolyze inhibitor palmitoylisopropylamine onto the serosal surface of bladders also increased the reflex activity both in naive and cyclophosphamide-injected rats. This latter effect in naive animals was blocked by capsazepine and by resiniferatoxin pretreatment. Finally, intravesical instillation of anandamide (50 microm) increased c-fos expression in the spinal cord, which was reduced by capsazepine or by resiniferatoxin pretreatment. These results suggest that anandamide, through activating TRPV1, contributes to the development of hyperreflexia and hyperalgesia during cystitis.

Indexed as

AcroleinAnimalsArachidonic AcidsCapsaicinCyclophosphamideCystitisEndocannabinoidsFemaleHydrolysisIon ChannelsPainPolyunsaturated AlkamidesPosterior Horn CellsProto-Oncogene Proteins c-fosRatsRats, WistarAcroleinanandamideArachidonic AcidsCapsaicincapsazepineCyclophosphamideEndocannabinoidsIon ChannelsPolyunsaturated AlkamidesProto-Oncogene Proteins c-fosReceptor, Cannabinoid, CB1Trpv1 protein, ratTRPV Cation Channels

Identifiers

PMID15601931
PMCPMC6730374
OpenAlexW2024424546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.